Literature DB >> 7535401

Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis.

G Walkinshaw1, C M Waters.   

Abstract

Death of neuronal cells during development and following deprivation of trophic factors is known to occur via an active mechanism requiring RNA and protein synthesis, known as apoptosis. Apoptosis is a form of cell "suicide" whereby the cell decides its own fate by activating a genetic programme of cell death. In contrast, necrosis is a passive uncontrolled form of cell death often observed in response to a toxic insult. Although it is known that neuronal cell death during development occurs by apoptosis, the mechanisms underlying neurotoxin-induced neuronal cell death remain poorly understood. In this study we have examined the mechanism by which 6-hydroxydopamine, a specific neurotoxin for catecholaminergic cells, induces neuronal cell death in vitro. We report that 6-hydroxydopamine induces cell death in the neuronal PC12 cell line via a mechanism which has the characteristic morphological and biochemical hallmarks of apoptosis. PC12 cells induced to die by 6-hydroxydopamine treatment exhibited cell shrinkage, classical chromatin condensation and membrane blebbing. Analysis of DNA integrity from 6-hydroxydopamine-treated cells revealed cleavage of DNA into regular sized fragments, a biochemical hallmark of apoptosis. 6-Hydroxydopamine-induced apoptosis of PC12 cells was suppressed by desipramine, a monoamine uptake inhibitor, suggesting that 6-hydroxydopamine is initiating apoptosis via a specific intracellular mechanism. Aurintricarboxylic acid, a general inhibitor of nucleases, also suppressed 6-hydroxydopamine-induced apoptosis, suggesting the involvement of an endonuclease in the death pathway. The aetiology of idiopathic Parkinson's disease remains uncertain, although evidence suggests that endogenous and/or exogenous toxins may initiate neuronal cell death in this disease. The dopaminergic neurotoxin 6-hydroxydopamine is used to generate animal models of Parkinson's disease in vivo. We have demonstrated that this neurotoxin kills neuronal cells in vitro by an active process of apoptosis. Thus, the possibility exists that cell death in neurodegenerative diseases such as Parkinsonism also occurs in an active manner initiated by as yet unidentified environmental or metabolic toxins. Cell death that involves activation of an apoptotic programme can be modulated by addition of extracellular trophic factors, and is also controlled by the levels of intracellular factors. If neurotoxin-induced apoptosis plays a role in Parkinson's disease the implication is that the neuronal degeneration may be prevented by pharmacological manipulations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535401     DOI: 10.1016/0306-4522(94)90566-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  30 in total

1.  Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway.

Authors:  M Rodríguez; T González-Hernández
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

2.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 3.  The role of apoptosis in neurodegenerative diseases.

Authors:  P Desjardins; S Ledoux
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

4.  Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra.

Authors:  M J Marti; C J James; T F Oo; W J Kelly; R E Burke
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

5.  Inhibition by anandamide of 6-hydroxydopamine-induced cell death in PC12 cells.

Authors:  Katarzyna Mnich; David P Finn; Eilis Dowd; Adrienne M Gorman
Journal:  Int J Cell Biol       Date:  2010-02-16

6.  L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.

Authors:  Liting Luo; Jingkao Chen; Dan Su; Meihui Chen; Bingling Luo; Rongbiao Pi; Lan Wang; Wei Shen; Rikang Wang
Journal:  Neurochem Res       Date:  2017-01-11       Impact factor: 3.996

7.  Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for neuroprotective assays relevant to Parkinson's disease.

Authors:  Cristina Malagelada Grau; Lloyd A Greene
Journal:  Methods Mol Biol       Date:  2012

8.  Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis.

Authors:  J K Callaway; P M Beart; B Jarrott; S F Giardina
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

9.  Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease.

Authors:  Kasthuri Bai Magalingam; Ammu Radhakrishnan; Premdass Ramdas; Nagaraja Haleagrahara
Journal:  J Mol Neurosci       Date:  2014-08-17       Impact factor: 3.444

10.  Resistance to the apoptotic effect of aggregated amyloid-beta peptide in several different cell types including neuronal- and hepatoma-derived cell lines.

Authors:  M Mazziotti; D H Perlmutter
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.